GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Asset Writedowns and Impairment (2015 - 2016)

Updated

Gsk (GSK) recorded Asset Writedowns and Impairment of $580.87 million in the year ended Dec 31, 2023, down 2.4% from $595.29 million a year earlier.

Analysis

Gsk (GSK) Asset Writedowns and Impairment (2015 - 2016) Analysis & Trends

Starting with the year ended Dec 31, 2013, Gsk's Asset Writedowns and Impairment history includes 6 years.

  • The figure for the year ended Dec 31, 2023 is the lowest annual Asset Writedowns and Impairment since the year ended Dec 31, 2014.
  • Per Business Quant data, GSK's Asset Writedowns and Impairment was $595.29 million in the year ended Dec 31, 2022 (-18.2%) and $727.84 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 36.05 Mn
Sep 30, 2016 -11.83 Mn
Jun 30, 2016 2.83 Bn
Mar 31, 2016 1.15 Bn
Dec 31, 2015 312.60 Mn
API Access

Gsk Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=GSK&period=max&api_key=YOUR_API_KEY